Market Place
Sourcing Support
Breckenridge Enters Strategic Partnership with Maiva Pharma
11 Mar 2026 //
PR NEWSWIRE
Breckenridge Announces Strategic Collaboration with Medichem
06 Feb 2026 //
PR NEWSWIRE
Breckenridge Gets FDA Nod For Everolimus Oral Suspension
29 Jan 2025 //
PR NEWSWIRE
Natco Pharma and Breckenridge dismissed from antitrust lawsuit
21 Dec 2023 //
INDIAN PHARMA POST
Breckenridge Distillery Announces Beer Collaboration With Breckenridge Brewery
19 Oct 2022 //
GLOBENEWSWIRE
Breckenridge Announces Approval of its ANDA for Cabazitaxel Intravenous Solution
01 Aug 2022 //
PRNEWSWIRE
Natco Pharma`s partner Breckenridge gets FDA nod for prostate cancer drug
25 Jul 2022 //
ECONOMIC TIMES
Breckenridge Distillery to Release New Collectors Art Series with Denver
25 Apr 2022 //
GLOBENEWSWIRE
Breckenridge Announces Tentative Approval of its ANDA for Dabigatran Etexilate
22 Apr 2022 //
PRNEWSWIRE
Breckenridge Signs New-Product Agreement with PTS Pharma
22 Apr 2022 //
PRNEWSWIRE
Breckenridge Announces Approval of its ANDA for Miglustat Capsules
21 Apr 2022 //
PRNEWSWIRE
Breckenridge Announces Launch of Penicillamine Capsules, USP
20 Apr 2022 //
PRNEWSWIRE
Breckenridge Launches Lacosamide Tablets Manufactured by MSN Laboratories
19 Apr 2022 //
PRNEWSWIRE
Breckenridge Pharma launches generic Afinitor in US market
01 Oct 2021 //
PHARMABIZ
Breckenridge Announces Launch of its 10mg strength for Everolimus Tab
01 Oct 2021 //
PRNEWSWIRE
Breckenridge Announces Approval of its ANDA for Teriflunomide
29 Sep 2021 //
PRESS RELEASE
Breckenridge Announces Approval of its ANDA for Teriflunomide Tablets (generic for Aubagio®)
29 Sep 2021 //
PRNEWSWIRE
Breckenridge Pharmaceutical Launches Norepinephrine Bitartrate Injection USP
20 Aug 2021 //
PRNEWSWIRE
Breckenridge Announces Final Approval of its ANDA for Apixaban Tablets
05 Aug 2021 //
PRNEWSWIRE
Breckenridge Announces Launch of Zolpidem Tartrate Extended-Release Tablets
08 Jul 2021 //
PR NEWSWIRE
Breckenridge Signs Multi-Product Agreement With Aggrega Pharma LLC
22 Jun 2021 //
PRNEWSWIRE
Breckenridge Announces Approval of its ANDA for Carfilzomib Intravenous Powder
16 Jun 2021 //
PRNEWSWIRE
Breckenridge Announces Approval of its ANDA for Carfilzomib Intravenous Powder
16 Jun 2021 //
BIOSPACE
Breckenridge Announces Final Approval of its ANDA for Everolimus Tablets
08 Mar 2021 //
PRNEWSWIRE
Breckenridge Announces Final Approval of its ANDA for Everolimus Tablets
08 Mar 2021 //
PRNEWSWIRE
Breckenridge got Final Approval of its ANDA for Asenapine 5 mg Sublingual Tablet
08 Mar 2021 //
PRNEWSWIRE
Breckenridge Announces Final Approval of its ANDA for Asenapine Tablets
11 Dec 2020 //
PRNEWSWIRE
Natco Pharma’s partner, Breckenridge Pharma gets US FDA approval
16 Nov 2020 //
PHARMABIZ
Breckenridge Announces Final Approval of its ANDA for Rivastigmine
02 Dec 2019 //
PR NEWSWIRE
Natco, Onyx settle cancer drug patent litigation
01 Jun 2019 //
ECONOMIC TIMES
Breckenridge Announces Approval for 40mg Duloxetine Delayed-release Capsules
21 May 2018 //
PR NEWSWIRE
JDRF, ADA and Helmsley Charitable Trust Issue Request for Proposals
11 Apr 2018 //
PRESS RELEASE
Breckenridge announces approval of Hep B virus tablets
02 Apr 2018 //
BIOSPECTRUM
Breckenridge`s Announces Final Approval of its ANDA Entecavir tablets Baraclude®
27 Mar 2018 //
PR NEWSWIRE
Breckenridge Pharmaceutical, Inc. Announces Acquisition of 5 ANDA`s
03 Oct 2017 //
PR NEWSWIRE
Breckenridge Pharma Announces Final ANDA Approval for Azacitidine Inj Vidaza®
27 Jun 2017 //
FIERCE BIOTECH
Alembic Pharma`s partner launches drug for depressive disorder
04 Mar 2017 //
ECONOMIC TIMES
Natco Pharma Gets USFDA Approval for Leukemia Drug
07 Jan 2017 //
BUSINESS STANDARD
Breckenridge Signs Marketing Agreement with Gland for Seven Injectable Products
06 Dec 2016 //
PR NEWSWIRE
Breckenridge Announces Final ANDA Approval for Armodafinil Tablets
29 Nov 2016 //
PR NEWSWIRE
Breckenridge Announces Entry into Injectable Market
10 Nov 2016 //
PR NEWSWIRE
Breckenridge Pharmaceutical, Inc. Announces Final ANDA Approval for Lacosamide Tablets (Vimpat®)
03 May 2016 //
PR NEWS WIRE
Breckenridge Announces Approval for Gabapentin Oral Solution
17 Mar 2016 //
PR NEWSWIRE
Indian pharma firms gear up for US product launches: Report
08 Dec 2015 //
BUSINESS STANDARD
Breckenridge Announces Final Approval for Dutasteride Soft Gelatin Capsules
20 Nov 2015 //
PR NEWS WIRE
Breckenridge Announces Approval for Rabeprazole Sodium Delayed-Release Tablets
19 Nov 2015 //
PR NEWS WIRE
Breckenridge Pharmaceutical, Inc. Announces Final ANDA Approval for Desvenlafaxine XR Tablets (Pristiq®)
01 Jul 2015 //
PR NEWS WIRE
